Inv€$table CEO Pitch Series: Caroline Barelle, CEO of Elasmogen

Caroline Barelle, CEO of Elasmogen, took the time to grant us an interview straight from the latest Inv€$table event that took place on the 24th May 2016. In this exclusive interview, Caroline elaborates on the development of the company's validated and IP protected soloMER platform and their pipeline of auto-immune and anti-inflammatory products focusing on utilizing soloMERs to enable site-specific delivery of therapeutics.

Watch the exclusive interview with Caroline Barelle

For more exclusive video interviews and pitches,visit here.

Interested in an invitation to attend our future Inv€$tables or looking for investment partners to connect with? Register your interest here.

Inv€$tables are a unique series of breakfast forums where life science companies pitch, profile andconnect with capital and partners. High calibre company CEO’s are selected to deliver 15 minute pitches to an audience of active, qualified investors and Pharma. CEOs are also afforded 15 minute profiling interviews followed by a 40 minute speed networking session and curated 1-2-1s.

Company Executives will have their video pitch, interview and an accompanying corporate profile released onto Biotech and Money's exclusive online portal post-event.All this from a commitment of just 3 hours.

Our next Inv€$table event will take place on 28th June at Gill Jennings & Every Offices, Broadgate Tower, 20 Primrose Street, London EC2A 2ES from 8.00-11.00am.

Author Blog
Written By

Add Your Response